针对子痫前期风险个体的照护计划:教育、预防、监测和随访的共同方法
每日低剂量阿司匹林早期开始可适度降低子痫前期发生,但长期对婴儿影响信息不足,故不推荐所有孕妇使用。多个专家团队已确定临床风险因素以推荐低剂量阿司匹林预防,并可辅以生化或生物物理检测。本文召集多领域专家组,采用GRADE方法制定针对中高危子痫前期风险个体的照护计划,涵盖教育、预防、监测和随访。
要点
- 低剂量阿司匹林早期开始可适度降低子痫前期发生,但长期对婴儿影响信息不足,不推荐所有孕妇使用。
- 多个专家团队已确定临床风险因素以推荐低剂量阿司匹林预防,可辅以生化或生物物理检测识别风险。
- 照护计划针对中高危子痫前期风险个体,采用GRADE方法呈现推荐及证据质量。
核心结论
- 针对中高危子痫前期风险个体,采用共同照护方法可能促进子痫前期及其近期和长期疾病的预防。
研究设计与样本
- 召集具有相关专业知识的多元专家组(临床医生、研究者、倡导者及公共和私人利益相关者)制定照护计划。
- 照护计划针对经临床和/或实验室检查确定为中高危、足以接受低剂量阿司匹林治疗的子痫前期风险个体。
- 推荐采用GRADE方法呈现,并附有每个推荐所基于的证据质量。
主要发现
- 每日低剂量阿司匹林早期开始可适度降低子痫前期发生。
- 低剂量阿司匹林似乎安全,但长期对婴儿影响信息不足,故不推荐所有孕妇使用。
- 多个专家团队已确定临床风险因素以推荐低剂量阿司匹林预防治疗。
- 风险因素可辅以生化或生物物理检测,以指示有临床风险因素者子痫前期概率增加,或识别无其他明显风险者的可能性增加。
关键数值与推荐
- 推荐对经临床和/或实验室检查确定为中高危、足以接受低剂量阿司匹林治疗的子痫前期风险个体提供照护计划(GRADE方法,证据质量见原文)。
临床怎么用
- 提供患者和提供者教育、增加监测、行为改变及其他改善结局的方法。
- 提供者可利用可打印附录中针对患者和医疗保健提供者的照护计划推荐简明摘要。
局限性
- 低剂量阿司匹林长期对婴儿影响的信息不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia is a multisystemic disorder of pregnancy that affects 250,000 pregnant individuals in the United States and approximately 10 million worldwide per annum. Preeclampsia is associated with substantial immediate morbidity and mortality but also long-term morbidity for both mother and offspring. It is now clearly established that a low dose of aspirin given daily, beginning early in pregnancy modestly reduces the occurrence of preeclampsia. Low-dose aspirin seems safe, but because there is a paucity of information about long-term effects on the infant, it is not recommended for all pregnant individuals. Thus, several expert groups have identified clinical factors that indicate sufficient risk to recommend low-dose aspirin preventive therapy. These risk factors may be complemented by biochemical and/or biophysical tests that either indicate increased probability of preeclampsia in individuals with clinical risk factors, or more importantly, identify increased likelihood in those without other evident risk. In addition, the opportunity exists to provide this population with additional care that may prevent or mitigate the short- and long-term effects of preeclampsia. Patient and provider education, increased surveillance, behavioral modification, and other approaches to improve outcomes in these individuals can improve the chance of a healthy outcome. We assembled a group with diverse, relevant expertise (clinicians, investigators, advocates, and public and private stakeholders) to develop a care plan in which providers and pregnant individuals at risk can work together to reduce the risk of preeclampsia and associated morbidities. The plan is for care of individuals at moderate to high risk for developing preeclampsia, sufficient to receive low-dose aspirin therapy, as identified by clinical and/or laboratory findings. The recommendations are presented using the GRADE methodology with the quality of evidence upon which each is based. In addition, printable appendices with concise summaries of the care plan's recommendations for patients and healthcare providers are provided. We believe that this shared approach to care will facilitate prevention of preeclampsia and its attendant short- and long-term morbidity in patients identified as at risk for development of this disorder.
引用
- Roberts JM, King TL, Barton JR, et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gynecol. 2023. PMID: 37120055. doi:10.1016/j.ajog.2023.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。